<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam##2200000za#4500</marc:leader>
    <marc:controlfield tag="001">9.576273</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20210624185048</marc:controlfield>
    <marc:controlfield tag="007">cr |||||||||||</marc:controlfield>
    <marc:controlfield tag="008">150406|2013||||xxc|||||o    f|0| 0 eng|d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">YC17-0/411-20E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="110" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada. </marc:subfield>
      <marc:subfield code="b">Parliament. </marc:subfield>
      <marc:subfield code="b">Senate. </marc:subfield>
      <marc:subfield code="b">Standing Committee on Social Affairs, Science and Technology.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="1" ind2="0">
      <marc:subfield code="a">Prescription pharmaceuticals in Canada : </marc:subfield>
      <marc:subfield code="h">[electronic resource]</marc:subfield>
      <marc:subfield code="b">post approval monitoring of safety and effectiveness / </marc:subfield>
      <marc:subfield code="c">The Honourable Kelvin K. Ogilvie, Chair ; The Honourable Art Eggleton, P.C., Deputy Chair. </marc:subfield>
    </marc:datafield>
    <marc:datafield tag="260" ind1=" " ind2=" ">
      <marc:subfield code="a">Ottawa - Ontario : </marc:subfield>
      <marc:subfield code="b">Senate. </marc:subfield>
      <marc:subfield code="c">March 2013.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">42p.</marc:subfield>
      <marc:subfield code="b">references, photographs</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="490" ind1="1" ind2=" ">
      <marc:subfield code="a">Report of the Standing Senate Committee on Social Affairs, Science and Technology</marc:subfield>
      <marc:subfield code="v">[41st Parliament, 1st Session, 20th report]</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="590" ind1=" " ind2=" ">
      <marc:subfield code="a">13-14</marc:subfield>
      <marc:subfield code="b">2013-04-05</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Les produits pharmaceutiques sur ordonnance au Canada : </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.605531</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="830" ind1="#" ind2="0">
      <marc:subfield code="a">Report of the Standing Senate Committee on Social Affairs, Science and Technology ;</marc:subfield>
      <marc:subfield code="v">[41st Parliament, 1st Session, 20th report]</marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.505256</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="a">http://publications.gc.ca</marc:subfield>
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">4413 KB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2013/sen/yc17-0/YC17-0-411-20-eng.pdf</marc:subfield>
      <marc:subfield code="y">[41st Parliament, 1st Session, 20th report]</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
